IDEAYA Biosciences, Inc. (IDYA)
NASDAQ·Healthcare·Biotechnology
$29.13
-1.19%
Mkt Cap $2.70B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 17, 2026 | $6.31M | $10.88M | +72.47% | -$0.95 | -$0.94 | +1.23% | — | — |
| Q4 2025 Nov 4, 2025 | $5.95M | $207.83M | +3395.08% | -$0.95 | $1.33 | +240.60% | — | — |
| Q3 2025 Aug 5, 2025 | $2.00M | — | — | -$0.85 | -$0.88 | -3.53% | — | — |
| Q2 2025 May 6, 2025 | $2.40M | — | — | -$0.75 | -$0.82 | -9.33% | — | — |
| Q1 2025 Feb 13, 2025 | $2.50M | $7.00M | +180.56% | -$0.67 | -$1.49 | -122.39% | — | — |
| Q4 2024 Nov 4, 2024 | $4.31M | — | — | -$0.67 | -$0.60 | +10.45% | — | — |
| Q3 2024 Aug 6, 2024 | $4.83M | — | — | -$0.55 | -$0.68 | -23.64% | — | — |
| Q2 2024 May 7, 2024 | $4.45M | — | — | -$0.53 | -$0.53 | +0.00% | — | — |
| Q1 2024 Feb 20, 2024 | $8.84M | $3.92M | -55.64% | -$0.49 | -$0.52 | -6.12% | — | — |
| Q4 2023 Nov 7, 2023 | $7.84M | $8.04M | +2.53% | -$0.47 | -$0.46 | +2.13% | — | — |
| Q3 2023 Aug 10, 2023 | $4.51M | $3.54M | -21.42% | -$0.53 | -$0.50 | +5.66% | — | — |
| Q2 2023 May 9, 2023 | $4.79M | $7.88M | +64.51% | -$0.51 | -$0.49 | +3.92% | — | — |
| Q1 2023 Mar 7, 2023 | $7.00M | $4.02M | -42.54% | -$0.57 | -$0.50 | +12.28% | — | — |
| Q4 2022 Nov 8, 2022 | $6.64M | $29.70M | +347.15% | -$0.65 | $0.04 | +106.15% | — | — |
| Q3 2022 Aug 15, 2022 | $7.69M | $5.85M | -23.95% | -$0.57 | -$0.57 | +0.00% | — | — |
| Q2 2022 May 10, 2022 | $6.71M | $11.36M | +69.31% | -$0.41 | -$0.36 | +12.20% | — | — |
| Q1 2022 Mar 15, 2022 | $8.98M | $2.96M | -67.00% | -$0.31 | -$0.47 | -51.61% | — | — |
| Q4 2021 Nov 15, 2021 | $8.98M | $8.98M | -0.04% | -$0.29 | -$0.31 | -6.90% | — | — |
| Q3 2021 Aug 10, 2021 | $8.76M | $8.76M | +0.00% | -$0.07 | -$0.33 | -371.43% | — | — |
| Q2 2021 May 10, 2021 | $6.98M | $7.25M | +3.85% | -$0.28 | -$0.28 | +0.00% | — | — |